Skip to main content
SpringerLink
Log in

Commentary on “Attention-deficit hyperactivity disorder medication use is associated with testosterone hypofunction”

  • Comment
  • Published:
International Journal of Impotence Research Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ostdiek-Wille GP, Bavitz KC, Kohn TP, Deibert CM. Attention-deficit hyperactivity disorder medication use is associated with testosterone hypofunction-results from a national claims database analysis. Int J Impot Res. 2023. https://doi.org/10.1038/s41443-023-00805-2

    Article  PubMed  Google Scholar 

  2. Chatterjee-Chakrabarty S, Miller BT, Collins TJ, Nagamani M. Adverse effects of methylphenidate on the reproductive axis of adolescent female rats. Fertil Steril. 2005;84 Suppl 2:1131–8.

    Article  CAS  PubMed  Google Scholar 

  3. Khoubbieh F, Erdogan CS, Onel T, Yildirim E, Sumer E, Yaba A, et al. Effect of methylphenidate on the onset of puberty and reproductive organ development in rats. Physiol Behav. 2023;266:114204.

    Article  CAS  PubMed  Google Scholar 

  4. Wang LJ, Huang YH, Chou WJ, Lee SY, Tsai CS, Lee MJ, et al. Potential disturbance of methylphenidate of gonadal hormones or pubescent development in patients with attention-deficit/hyperactivity disorder: a twelve-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry. 2021;108:110181.

    Article  CAS  PubMed  Google Scholar 

  5. Ramasamy R, Dadhich P, Dhingra A, Lipshultz L. Case report: testicular failure possibly associated with chronic use of methylphenidate. F1000Res. 2014;3:207.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Minnesota, Minneapolis, MN, USA

    Onuralp Ergun

  2. Department of Urology, Hacettepe University, Ankara, Turkey

    Ahmet Gudeloglu

Authors
  1. Onuralp Ergun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmet Gudeloglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

OE: Writing- original draft. AG: Writing- review & editing.

Corresponding author

Correspondence to Onuralp Ergun.

Ethics declarations

Competing interest

Corresponding author (OE) is an associate-editor at IJIR: Your Sexual Medicine Journal but is not involved with any of this manuscript’s processing and/or reviewing stages.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ergun, O., Gudeloglu, A. Commentary on “Attention-deficit hyperactivity disorder medication use is associated with testosterone hypofunction”. Int J Impot Res (2024). https://doi.org/10.1038/s41443-024-00834-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41443-024-00834-5

  • Springer Nature Limited

Search

Navigation